Claude Vezeau
Directeur Général chez Bellus Health (Innodia), Inc.
Postes actifs de Claude Vezeau
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Bellus Health (Innodia), Inc.
 Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Bellus Health (Innodia), Inc. manufactures biopharmaceutical products for the treatment and prevention of amyloidosis, metabolic syndrome, and diabetics related diseases. The company was founded in 2002 and is headquartered in Laval, Canada. | Directeur Général | 01/01/2002 | - |
| Fondateur | 01/01/2002 | - | |
| President | 01/01/2002 | - |
Historique de carrière de Claude Vezeau
Anciens postes connus de Claude Vezeau
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Biochem Pharma, Inc.
 Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Biochem Pharma, Inc. provides bioinfomatics tools, biotechnology databases and consulting services to the genomics, proteomics and biopharmaceutical industries. They provide the cutting edge strategic intelligence needed to exploit information and to develop future business strategies. | President | - | - |
Formation de Claude Vezeau
| University of Minnesota | Doctorate Degree |
Statistiques
Internationale
| Canada | 3 |
| Etats-Unis | 2 |
Opérationnelle
| President | 2 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Bellus Health (Innodia), Inc.
Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Bellus Health (Innodia), Inc. manufactures biopharmaceutical products for the treatment and prevention of amyloidosis, metabolic syndrome, and diabetics related diseases. The company was founded in 2002 and is headquartered in Laval, Canada. | Health Technology |
Biochem Pharma, Inc.
Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Biochem Pharma, Inc. provides bioinfomatics tools, biotechnology databases and consulting services to the genomics, proteomics and biopharmaceutical industries. They provide the cutting edge strategic intelligence needed to exploit information and to develop future business strategies. | Health Technology |
- Bourse
- Insiders
- Claude Vezeau
- Expérience
